|
Studies of Normal and Neoplastic Prostate
|
5U01CA015062-33
|
$215,048
|
$43,010
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-05
|
$234,166
|
$35,125
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
NANOTHERAPEUTIC STRATEGY FOR MULTIDRUG RESISTANT TUMORS
|
5R01CA119617-04
|
$362,876
|
$119,749
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
SPORE in Breast Cancer
|
2P50CA098131-06
|
$2,300,000
|
$92,000
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$266,915
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
$19,302
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
7R01CA077091-05
|
$338,540
|
$338,540
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-34
|
$417,899
|
$62,685
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
2U10CA052667-18
|
$787,595
|
$110,263
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-04
|
$244,382
|
$12,219
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-29S1
|
$628
|
$144
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
3U10CA037429-24S1
|
$464,405
|
$51,085
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
|
5R01CA119409-04
|
$474,360
|
$118,590
|
Baker, James
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
5U10CA027057-29
|
$262,397
|
$60,351
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-29
|
$9,490,764
|
$2,182,876
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
7U10CA037429-24
|
$16,768,272
|
$1,844,510
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-11
|
$334,932
|
$150,719
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-09
|
$2,180,816
|
$436,163
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Clinical Studies of Multidrug Resistance Reversal
|
Z01 BC 010620
|
$113,917
|
$11,392
|
Bates, Susan
|
CCR (NCI)
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$225,656
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
The Gulf Coast MBCCOP
|
7U10CA128536-02
|
$539,869
|
$75,582
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-33
|
$452,395
|
$67,859
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
Geisinger Clinical Oncology Program
|
2U10CA035448-25
|
$599,474
|
$17,984
|
BERNATH, ALBERT
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Gynecologic Oncology Group Statistical and Data Center
|
5U10CA037517-24
|
$4,682,025
|
$3,886,081
|
BLESSING, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-11
|
$450,518
|
$202,733
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Treatment of Malignant Gliomas with 2-5A-anti-hTR
|
5R01CA108558-05
|
$293,510
|
$146,755
|
BOGLER, OLIVER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Fullerene Immunoconjugates for Cancer Imaging and Treatment
|
5R43CA128277-02
|
$206,967
|
$103,484
|
BOLSKAR, ROBERT
|
TDA RESEARCH, INC.
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
Z01 SC 006353
|
$610,988
|
$91,648
|
Brechbiel, Martin
|
CCR (NCI)
|
|
Southwest Oncology Group
|
5U10CA004919-49
|
$192,303
|
$44,230
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Cancer and Leukemia Group B-Leukemia Correlative Science
|
5U10CA101140-06
|
$1,000,836
|
$450,376
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
SPORE in Lung Cancer
|
5P50CA090949-07
|
$2,300,000
|
$460,000
|
CARBONE, DAVID
|
VANDERBILT UNIVERSITY
|
|
Molecular Signatures of Lung Cancer
|
5U01CA114771-04
|
$1,600,942
|
$160,094
|
CARBONE, DAVID
|
VANDERBILT UNIVERSITY
|
|
Cancer Research for the Ozarks
|
5U10CA045560-20
|
$681,391
|
$109,023
|
CAROLLA, ROBERT
|
OZARK HEALTH VENTURES, LLC
|
|
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
|
1R01CA138197-01
|
$475,325
|
$47,533
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Breast cancer response markers to a dual HER1/2 blocker
|
5R01CA112305-04
|
$252,236
|
$83,238
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
NSABP Participating Sites
|
5U10CA118735-03
|
$66,231
|
$3,312
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Array-assisted Insertional Mutagenesis Platform for Forward Genetics of Cancer
|
1R43CA132841-01
|
$92,940
|
$92,940
|
CHENCHIK, ALEX
|
CELLECTA, INC.
|
|
HAWAII MINORITY-BASED CCOP
|
3U10CA063844-15S1
|
$100,000
|
$8,000
|
Cho, Jonathan
|
UNIVERSITY OF HAWAII AT MANOA
|
|
HAWAII MINORITY-BASED CCOP
|
5U10CA063844-15
|
$778,279
|
$62,262
|
Cho, Jonathan
|
UNIVERSITY OF HAWAII AT MANOA
|
|
In Vivo Cancer Therapy Monitoring with Diffuse Optical Methods
|
1K99CA126187-01A1
|
$81,197
|
$8,120
|
CHOE, REGINE
|
UNIVERSITY OF PENNSYLVANIA
|
|
TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER
|
5R01CA123159-02
|
$278,768
|
$139,384
|
COLE, DAVID
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Northwest Community Clinical Oncology Program
|
2U10CA035281-25
|
$691,655
|
$89,915
|
COLMAN, LAUREN
|
TACOMA GENERAL HOSPITAL
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
|
3U10CA021115-34S1
|
$61,182
|
$9,177
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
|
5U10CA021115-34
|
$7,790,309
|
$1,168,546
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
ECOG CCOP Research Base
|
5U10CA037403-23
|
$1,797,715
|
$161,794
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-10
|
$644,464
|
$96,670
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Glucocorticoid receptor-mediated survival signaling in breast cancer
|
5R01CA089208-06
|
$226,927
|
$226,927
|
CONZEN, SUZANNE
|
UNIVERSITY OF CHICAGO
|
|
Clinical Oncology Program Biostatistical Center
|
3U10CA069974-13S1
|
$3,466,706
|
$624,007
|
COSTANTINO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Biostatistical Center for the NSABP
|
5U10CA069651-15
|
$3,800,453
|
$190,023
|
COSTANTINO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Clinical Oncology Program Biostatistical Center
|
5U10CA069974-13
|
$142,870
|
$25,717
|
COSTANTINO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
Total relevant funding to Taxol for this search: $63,184,616
|